title: Fosamprenavir: a new PI option. Interview by Craig Sterritt.
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Nadler
mesh_terms: D002219:Carbamates; D004359:Drug Therapy, Combination; D005663:Furans; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D010755:Organophosphates / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use*
chemical_list: D002219:Carbamates; D005663:Furans; D017320:HIV Protease Inhibitors; D010755:Organophosphates; D018894:Reverse Transcriptase Inhibitors; D013449:Sulfonamides; C426859:fosamprenavir